RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA takes first step in possible reversal of ban on some peptides The Washington Post The wellness world is eager for RFK Jr.'s promised move on peptides : NPR FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida